Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Genesis Healthcare's (GEN) Q3 Earnings Beat, Improve Y/Y
by Zacks Equity Research
Genesis Healthcare's (GEN) third-quarter results reflect same store occupancy growth, partly offset by lower revenues.
The Zacks Analyst Blog Highlights: Alibaba, General Electric, Anthem, Progressive and Pharmaceuticals
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alibaba, General Electric, Anthem, Progressive and Pharmaceuticals
Top Stock Reports for Alibaba, General Electric & Anthem
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group (BABA), General Electric (GE) and Anthem (ANTM).
Humana's (HUM) Q3 Earnings Surpass Estimates, Improve Y/Y
by Zacks Equity Research
Humana's (HUM) third-quarter results reflect higher revenues as well as solid membership growth.
Tenet Healthcare (THC) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter earnings gain from its Hospital and Other segment as well as volume growth.
MEDNAX (MD) Q3 Earnings In Line With Estimates, Decline Y/Y
by Zacks Equity Research
MEDNAX's (MD) results reflect escalating expenses in the third quarter.
Ensign Group's (ENSG) Q3 Earnings Miss Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) third-quarter earnings suffer escalating expenses.
Cigna (CI) Q3 Earnings & Revenues Beat Estimates, View Up
by Zacks Equity Research
Cigna (CI) Q3 results reflect higher revenues and membership from Express Scripts merger.
WellCare Health (WCG) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
WellCare Health's (WCG) third-quarter results reflect improved revenues.
Community Health's (CYH) Q3 Loss Narrower Than Expected
by Zacks Equity Research
Community Health's (CYH) third-quarter results reflect decreased admissions.
Molina Healthcare (MOH) Q3 Earnings Surpass, Increase Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter earnings benefit from lower expenses.
HCA Healthcare (HCA) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
HCA Healthcare's (HCA) third-quarter results gain traction from better revenues.
Universal Health's (UHS) Earnings Lag in Q3, Decline Y/Y
by Zacks Equity Research
Universal Health's (UHS) third-quarter results are hurt by high operating expenses.
Company News For Oct 24, 2019
by Zacks Equity Research
Companies In The News Are: ALXN,ANTM,TMO,BSX
Mixed Thrid-Quarter 2019 Earnings Results
by Zacks Equity Research
Mixed Q3 2019 Earnings Results
Q3 Morning Roundup: Boeing, Caterpillar & More
by Mark Vickery
Earnings reports take up the balance of pre-market news items, as we again see no new economic data ahead of today's opening bell.
Anthem's (ANTM) Q3 Earnings Beat Estimates, Improve Y/Y
by Zacks Equity Research
Anthem's (ANTM) third-quarter earnings gain from increased revenues.
Anthem (ANTM) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Anthem (ANTM) delivered earnings and revenue surprises of 0.62% and 4.07%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Walmart, AstraZeneca, Broadcom, Intuitive Surgical and Anthem
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Walmart, AstraZeneca, Broadcom, Intuitive Surgical and Anthem
Anthem (ANTM) Gears Up for Q3 Earnings: What's in Store?
by Zacks Equity Research
Anthem (ANTM) is likely to have gained from solid revenues in the third quarter.
Top Research Reports for Walmart, AstraZeneca & Broadcom
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Walmart (WMT), AstraZeneca (AZN) and Broadcom (AVGO).
Anthem (ANTM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Anthem (ANTM) closed at $249.41, marking a +0.06% move from the previous day.
Anthem (ANTM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Anthem (ANTM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Big Bank & Healthcare Earnings, Netflix Q3 Preview & Buy Lululemon Stock - Free Lunch
by Benjamin Rains
Breaking down some of Tuesday's major Q3 earnings results from giants such as JPMorgan Chase and UnitedHealth. A look at what to expect from Netflix's third quarter financials Wednesday. And why Lululemon is a Zacks Rank #1 (Strong Buy) stock...
Anthem (ANTM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Anthem (ANTM) closed at $237.55, marking a +0.13% move from the previous day.